Bertek Pharmaceuticals, Inc.

PharmaCare named a preferred specialty pharmacy provider of Apokyn

Published in Hospital and Nursing Home Week, May 27th, 2004

PharmaCare Specialty Pharmacy has been selected as a preferred specialty pharmacy provider by Bertek Pharmaceuticals, Inc., for Apokyn (apomorphine hydrochloride injection), a dopamine agonist drug indicated for the acute, intermittent treatment of hypomobility ("off" episodes) in patients that suffer from motor complications associated with advanced Parkinson disease.

"We're proud to partner with Bertek to provide convenient distribution of Apokyn," said Greg Weishar, president and CEO of PharmaCare. "Through our unique patient support services, PharmaCare will assist patients and caregivers by answering questions, plus provide coordinated delivery of Apokyn by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week

Source: Hospital and Nursing Home Week (2004-05-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry